Ultimovacs is Drug Discovery in Norway that focus on peptide-based vaccine business. Founded in 2011. They cover business area such as Ultimovacs ASA, novel immunotherapy, cancer, its product candidate, t cell response, its proprietary technology.
2011
( 13 years old in 2024 )
Peptide-based Vaccine
-
Ullernchausséen 64
0379 Oslo
Norway
Private
Ultimovacs ASAnovel immunotherapycancerits product candidatet cell responseits proprietary technology
* We use standard office opening hours in near Ultimovacs's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ultimovacs is Drug Discovery business from Norway that founded in 2011 (13 years old in 2024), Ultimovacs business is focusing on Peptide-based Vaccine.
Ultimovacs headquarter office and corporate office address is located in Ullernchausséen 64 0379 Oslo Norway.
Ultimovacs was founded in Norway.
In 2024, Ultimovacs is currently focus on peptide-based vaccine sector.
Above is snippet of Google Trends for "peptide-based vaccine" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ultimovacs, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
